Monitoring muscle loss in patients after severe stroke
Follow up of Strength and Body Composition With Impedancemeter Device During the First 10 Days After Acute Stroke.
This study looks at how muscle strength and body changes happen in people who have had a severe stroke during their first 10 days in the hospital to better understand muscle loss.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 260 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Régional d'Orléans Academic / other |
| Locations | 1 site (Orleans) |
| Trial ID | NCT06603701 on ClinicalTrials.gov |
What this trial studies
This study aims to observe the changes in muscle strength and body composition in patients who have experienced a severe stroke within the first 10 days of hospitalization. By utilizing bioimpedancemetry and dynamometry, researchers will assess the evolution of sarcopenia and identify predictive factors such as age, sex, and initial neurological deficits. The study focuses on understanding how immobilization and other factors contribute to muscle loss in stroke patients, particularly in Western populations, where data is limited compared to Asian studies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have suffered an acute stroke and have limited mobility.
Not a fit: Patients with other neurological or rheumatological conditions that limit mobility or those under legal guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for preventing sarcopenia in stroke patients, enhancing recovery outcomes.
How similar studies have performed: While many studies have explored sarcopenia in Asian populations, this approach is novel in Western contexts, where similar data is scarce.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute stroke patient * Over 18 years of age * Functional Ambulation Categories (FAC) \< 3 * NIHSS upper limb score ≥ 1 * Able to understand assessment instructions * Non-objection to the study * Affiliated with a social security scheme Exclusion Criteria: * Person under guardianship or curatorship. * Person deprived of liberty * Person under court protection * Other neurological or rheumatological pathology limiting mobility * Presence of a pacemaker or defibrillator. * Pregnant or breast-feeding woman
Where this trial is running
Orleans
- CHU d'ORLEANS — Orleans, France (Recruiting)
Study contacts
- Principal investigator: Canan OZSANCAK, PH — CHU Orléans
- Study coordinator: Canan OZSANCAK, PH
- Email: canan.ozsancak@chu-orleans.fr
- Phone: +33238229971
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.